Julex Capital Management’s Biogen BIIB Stock Holding History

Julex Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9	Closed	-$2K	–	173
2019 Q2	$2K	Buy	+9	New	+$2.08K	﹤0.01%	63

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Julex Capital Management's BIIB Position: Q3 2019 in Review

Julex Capital Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 9 shares — an estimated $2K sold.

Julex Capital Management first reported a position in BIIB in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Julex Capital Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Julex Capital Management sold 9 Biogen shares in Q3 2019, an estimated $2K.
Julex Capital Management first reported a position in Biogen in Q2 2019 and held it in 1 quarter.
Julex Capital Management's Biogen position peaked at $2K in Q2 2019.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Julex Capital Management's 13F filing for Q3 2019, filed 18 Oct 2019.